ALCAM

ALCAM Overview

English NameActivated leukocyte cell adhesion moleculeApproved Drugs0
Drugs in Clinical Trials1Target SynonymCD166 antigen,Activated leukocyte cell adhesion molecule,CD166,ALCAM,MEMD,Activated Leucocyte Cell Adhesion Molecule,Activated-Leukocyte Cell Adhesion Molecule
Highest Development StagePhase 2 Clinical
English NameActivated leukocyte cell adhesion molecule
Target SynonymCD166 antigen,Activated leukocyte cell adhesion molecule,CD166,ALCAM,MEMD,Activated Leucocyte Cell Adhesion Molecule,Activated-Leukocyte Cell Adhesion Molecule
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

ALCAM Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    Fc Tag (1)His Tag (1)

  • Conjugate

    Unconjugated (2)

Total: 2
  • 1

ALCAM Background

CD166 antigen is a 100-105 kD typeI transmembrane glycoprotein that is a member of the immunoglobulin superfamily of proteins, which is also known as Activated leukocyte cell adhesion molecule (ALCAM) in human, SC-1/DM-GRASP/BEN in the chicken, and KG-CAM in the rat. CD166 is a cell adhesion molecule that binds to CD6. CD166 involved in neurite extension by neurons via heterophilic and homophilic interactions.

ALCAM Synonyms

CD166,ALCAM,CD6L,KG-CAM,MEMD
  • Overview
  • Product List